poppk model of osimertinib
Interactive population PK simulator for osimertinib (Tagrisso) in NSCLC. Models parent drug and active AZ5104 metabolite with covariate effects (weight, albumin, ethnicity). Includes QTcF and exposure-response for rash/diarrhoea. Based on Planchard et al., Br J Clin Pharmacol 2016.
Drug Overview
Clinical Context
- Drug Class
- EGFR Tyrosine Kinase Inhibitor
- Therapeutic Area
- Oncology / NSCLC
Model Information
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for poppk model of osimertinib allows you to explore concentration-time profiles under different dosing scenarios. characterizes the pharmacokinetics of this egfr tyrosine kinase inhibitor.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the poppk model of osimertinib PK simulator?
This is a free, interactive pharmacokinetic simulator for poppk model of osimertinib. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does poppk model of osimertinib belong to?
poppk model of osimertinib is classified as a EGFR Tyrosine Kinase Inhibitor. It is used in the Oncology / NSCLC therapeutic area.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Ready to Simulate?
Launch the poppk model of osimertinib simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community